Previous Article | Next Article 
Infection and Immunity, August 2000, p. 4805-4810, Vol. 68, No. 8
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Antigen Specificity of T-Cell Response to
Mycobacterium avium Infection in Mice
Teresa F.
Pais,
Joana
Feijó
Cunha, and
Rui
Appelberg*
Laboratory of Microbiology and Immunology of
Infection, Institute for Molecular and Cell Biology, University of
Porto, Porto, Portugal
Received 29 February 2000/Returned for modification 31 March
2000/Accepted 5 May 2000
 |
ABSTRACT |
T cells from Mycobacterium avium-infected C57BL/6 mice
reacted to culture filtrate, envelope, and cytosol proteins and to fractions obtained from these proteins. Multiple targets were recognized, such as 29- to 45-kDa and <21-kDa antigens of the culture
filtrate, antigens of around 30 kDa in the envelope and cytosol, and
45- to 116-kDa proteins in the envelope.
 |
TEXT |
The identification of the key
antigenic targets of the immune response to mycobacteria is of pivotal
importance in the design and testing of new vaccine candidates against
mycobacterial pathogens, most notably Mycobacterium
tuberculosis. Work from several laboratories has identified
secreted/exported proteins from M. tuberculosis as the major
targets of a protective immune response to experimental tuberculosis
infections (2, 3, 5, 12, 13, 17, 18, 20). These antigens are
also favored targets during an immune response in human patients
infected with the tubercle bacilli (17). However, other
proteins believed not to be excreted by the mycobacterial cells have
also been identified as important targets, namely in the induction of
protective immune responses in experimental animals (14,
23), suggesting that the complete picture of the immune response
to mycobacterial infections may be more complex with regard to the
antigenic repertoire recognized in vivo. Mycobacterium avium
is an opportunistic pathogen that is thought to interfere, in certain
areas of the world, with the efficacy of the only tuberculosis vaccine
in use today, the attenuated Mycobacterium bovis strain
bacille Calmette-Guérin (BCG) (9). The reason for the
failure of vaccination trials is not known, but it has been speculated
that sensitization of human beings to antigens from environmental
mycobacteria might affect BCG efficacy, most likely because all
mycobacteria would share common antigens. Sharing of antigens between
nontuberculous mycobacteria and BCG was already shown to occur at the
immunological level in mice (15). However, except for two
defined antigens, the latter study used crude extracts that combined
many different antigens. The sharing of common antigens between
M. avium, BCG, and M. tuberculosis will be
understood in the near future thanks to efforts in the area of
genomics. However, we still need studies in the fields of proteomics
and immunology to generate functional data and therefore to be
able to critically analyze the genomic information, namely studying
native proteins rather than recombinant ones, as the latter may lack
the immunogenicity of the former (1, 21). Thus, we initiated
the characterization of the T-cell response to M. avium protein antigens using a mouse model of infection.
We isolated antigens from M. avium 2447, an AIDS patient
isolate obtained from F. Portaels (Institute of Tropical Medicine, Antwerp, Belgium) that forms smooth transparent colonies when cultured
on solid media. Mycobacteria from log-phase cultures were inoculated
into Sauton medium enriched with 0.5% sodium pyruvate and 0.5%
glucose (Sauton P+G) (8) and with no detergent, at a final
concentration of approximately 5 × 106 CFU/ml
(according to the absorbance measured at 600 nm), and grown at 37°C
without shaking. The number of viable bacteria and the smooth
transparent morphotype were confirmed by plating serial dilutions of
the cultures on solid Middlebrook 7H10 medium (Difco, Sparks, Md.). At
the end of log phase (i.e., at day 15 as evaluated from the previous
growth curves), cultures were centrifuged for processing of bacterial
antigens. Culture filtrate proteins were obtained from the
filter-sterilized supernatant of the culture by ultrafiltration in a
stirred cell (Millipore, Bedford, Mass.) with an Amicon YM membrane
(molecular weight cut-off [MWCO] of 3,000) (Millipore). The
concentrate was precipitated with 80% ammonium sulfate, and the
precipitate was washed in a Centriprep (MWCO of 3,000) (Millipore).
Cytosolic and envelope proteins were obtained after the pellet was
washed twice with phosphate-buffered saline (PBS), resuspended in PBS
containing 0.1% Tween 80 (Sigma), 1 mM MgCl2 (Merck,
Darmstadt, Germany) and 1 mM benzamidine (Sigma) (10),
and disrupted through sonication with pulses of 1 min at maximum power,
with the sample kept in ice during the whole procedure. The sonicate
was centrifuged to discard intact mycobacteria (30 min at
2,700 × g), and the supernatant was dialyzed against PBS (MWCO of 12,000). The suspension was then ultracentrifuged for
2 h at 150,000 × g. The pellet containing the
envelope proteins was resuspended in PBS, and the supernatant enriched
in cytosolic proteins was precipitated with 80% ammonium sulfate and
dialyzed against PBS.
Following the preparative procedures described above, we obtained crude
extracts which were analyzed to assess if they were distinct
sources of antigens. Cytosolic, envelope, and culture filtrate proteins
(20 µg) were separated in a 10 to 20% gradient sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gel and analyzed
either by silver staining or by Western blotting after transfer to a
PROTON nitrocellulose (Schleicher and Schuell, Dassel,
Germany) membrane in a semidry electrophoretic transfer cell
(Bio-Rad, Richmond, Calif.). During the latter procedure, the membrane
was blocked in PBS containing 0.5% Tween 20 (Sigma), incubated for
2 h at room temperature with the antibodies diluted (1:50) in
PBS-0.05% Tween-0.37 M NaCl, and washed in the dilution buffer. The
primary antibodies used were specific for DnaK (clone HÅT 3), GroEL
(clone HÅT 5), GroES (clone HYB 76-1), and Ag85 (clone HYT 27), and
they were kindly provided by Peter Andersen (Statens
Seruminstitut, Copenhagen, Denmark). The secondary antibody, a
horseradish peroxidase-coupled sheep anti-mouse antibody
(Amersham-Pharmacia Biotech, Little Chalfont, United Kingdom) was
incubated at a 1:500 dilution for 2 h at room temperature.
The specific protein complexes were detected using the ECL reagents
(Amersham-Pharmacia Biotech).
The protein profiles observed in the silver-stained gels for the three
fractions were different, with distinct, different major bands
obtained with the three preparations (Fig.
1A). The immunochemical analysis by the
Western blotting with the panel of monoclonal antibodies against
well-defined mycobacterial proteins (DnaK, GroEL, Ag85 complex,
and GroES) showed that the three protein preparations
corresponded to distinct cellular compartments. Thus, the DnaK and GroES proteins were mostly found in the cytosolic preparations, whereas the GroEL protein was found exclusively in
the envelope fraction. Although we could find Ag85 in all three compartments, the molecular weight (MW) pattern varied, with higher-MW forms being found in the cytosol and envelope and a lower-MW form being
found in the culture filtrate. We thus conclude that the culture
filtrate and envelope preparations have negligible contamination with
cytosol proteins. These preparations were then studied in terms of
their ability to stimulate T cells isolated from infected mice.
Six-week-old C57BL/6J female mice (Harlan Iberia, Madrid, Spain) were
infected intravenously with 106 CFU of M. avium
2447 (smooth transparent morphotype) through a lateral tail vein at
different time points and sacrificed on the same day at different times
of infection to perform the in vitro stimulation of splenic cells. At
days 15, 30, 60, and 90 after infection, spleens were removed and
single-cell suspensions were prepared. Cells were washed with RPMI-2%
fetal calf serum (FCS), and the erythrocytes were lysed with a
hemolytic solution (155 mM NH4Cl-10 mM KHCO3,
pH 7.2). The cells were cultured in Dulbecco's modified Eagle medium
(Life Technologies, Paisley, United Kingdom) supplemented with HEPES
buffer, pyruvate, and 10% FCS. The cells were cultured in
96-well, round-bottom, microtiter tissue culture plates (Nunc,
Roskilde, Denmark), each well containing 2 × 105
cells in a volume of 200 µl with no stimulus or incubation in the
presence of antigen at a final concentration of 4 µg of crude extract/ml. Culture supernatants from triplicate wells were harvested 72 h later for the detection of gamma interferon (IFN-
) as a readout of the response of those T cells to the different antigens using an enzyme-linked immunosorbent assay (ELISA) as previously described (22). As shown in Fig.
2, the envelope
proteins were strong stimulators of IFN-
production from day 15 of
infection. The three preparations had antigens that stimulated T cells
from mice infected for 30, 60, or 90 days, with the highest amount of
IFN-
being produced at day 30 of infection.

View larger version (43K):
[in this window]
[in a new window]
|
FIG. 1.
Analysis of crude extracts of M. avium 2447 proteins. Cytosol (Cyt.), envelope (Env.), and culture filtrate (CF)
preparations were analyzed by gradient (10 to 20%) SDS-PAGE followed
by silver staining (A) or transferred to nitrocellulose and incubated
with antibodies against DnaK, GroEL, Ag85 complex, or GroES followed by
ECL-dependent detection of antigen-positive bands (B).
|
|

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 2.
Antigenicity of the crude extracts of M. avium 2447 proteins. Single-cell suspensions were prepared from
spleens of mice infected for 15 (T15), 30 (T30), 60 (T60), or 90 (T90)
days with M. avium 2447 or noninfected (naive) animals and
stimulated in vitro with 4 µg of cytosol, envelope, or culture
filtrate proteins per ml. IFN- release was quantified by ELISA in
the 72-h culture supernatants. Results are expressed as means of values of
triplicate samples ±1 standard deviation performed on cells pooled
from four mice. Statistically significant differences compared to
values for nonstimulated cells are labeled: *, P < 0.05; **, P < 0.01; ***, P = 0.00.
|
|
To obtain panels of MW fractions from the culture filtrate, envelope,
and cytosol preparations, the multielution technique (4) was
used. Briefly, 7 mg of culture filtrate or cytosolic proteins or 9 mg
of envelope proteins was separated by SDS-PAGE (with a gradient gel of
10 to 20% acrylamide), and the gel was prepared for electroelution as
described before (4). The proteins were electroeluted (40 V)
for 20 min into a 2-mM phosphate buffer in a whole-gel eluter (Bio-Rad)
in a cold room. The fractions were collected and analyzed (40 µl of
each fraction) in a gradient SDS-PAGE (10 to 20% acrylamide) after
fixation and silver staining (16). Protein concentration was
quantified by the Micro BCA method (Pierce, Rockford, Ill.). The
fractions were stabilized with 0.5% FCS in PBS. The SDS-PAGE analysis
of the fractions obtained showed that most of them contained proteins
in a very narrow range of MWs (Fig. 3),
thereby greatly reducing the complexity of the crude extracts. The
fractions obtained were then used to study the antigenic specificity of
the T cells from infected mice, as detailed above (Fig.
4). The in vitro stimulation of spleen
cells with the MW fractions obtained from the three different
compartments at a final concentration of 2 µg/ml showed that the
response to the culture filtrate fractions emerged at day 15, earlier
than the response to the cytosol or envelope fractions. At day 30 of infection, the peak of the response, the strongest stimulators of T
cells were found among fractions of culture filtrate in the 29,000-to-45,000 MW range. Fraction 13 from the culture filtrate, which
was enriched in proteins in the 30-kDa region (where proteins such as
Ag85 complex, a group of proteins that are highly immunogenic among
mycobacteria (11, 24), are expected to locate), induced the
strongest IFN-
production. Fractions 12 of the cytosol and envelope,
which contain proteins in the same region of MW, were also very
immunogenic. Fractions from the envelope between 45 and 116 kDa
contained highly stimulatory proteins that were absent from the
corresponding MW fractions of the culture filtrate. On the other hand,
there was a group of fractions in the culture filtrate below 21 kDa
(fractions 17 to 21), which did not include the lowest-MW fractions,
that were also inducers of IFN-
production.

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 3.
Fractionation of cytosol, envelope, and culture filtrate
(CF) proteins. Proteins were separated by SDS-PAGE and electroeluted as
described in the text. The different MW fractions were analyzed on a
silver-stained SDS-PAGE gel.
|
|

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 4.
Antigenicity of the fractions obtained from cytosol,
envelope, and culture filtrate proteins (the fraction numbers on this
figure correspond to the numbers in Fig. 3). Spleen cells of
noninfected mice or mice infected with M. avium 2447 were
stimulated in vitro with 2 µg of each fraction per ml. IFN-
release was quantified by ELISA with culture supernatants.
|
|
The antigen repertoire recognized by IFN-
-secreting T cells during
an M. avium infection in mice revealed a highly diverse set
of protein antigens. The antigen targets were not confined to the
secreted/exported proteins but rather were promiscuous among all
compartments of the mycobacterial cell when grossly dissected into
secreted/exported (culture filtrate), envelope, and cytoplasmic
proteins. Several groups have favored secreted/exported proteins as the
major targets of the protective immune response to M. tuberculosis (2, 3, 5, 12, 13, 17, 18, 20). In
addition, cell wall-associated proteins have also been shown to evoke
an immune response during infection (17), suggesting their
shedding from the cell wall during growth of mycobacteria inside the
vacuoles of the infected macrophage. Finally, the response to
cytoplasmic antigens would, according to some, appear later in
infection as a result of the killing of the mycobacteria, and this
response would be associated not with a protective IFN-
-mediated immune response but most likely with a type 2 immune response, which is
putatively associated with removal of the dead mycobacteria (19). Our data confirm the above paradigm by showing
important reactivity towards secreted/exported as well as envelope
proteins. However, IFN-
-secreting T cells were also found to
respond to the cytosolic proteins, namely to fractions of around 30 to
32 kDa, characteristic of the Ag85 complex. Although it is believed that this is a typical secretion antigen (24, 25), we
detected its presence in both the somatic (cytosol and envelope) and
secreted fractions. Curiously, the former forms had a higher MW than
the secreted form. The fact that Ag85 is found in the envelope is not
surprising due to its function in the synthesis of the cell wall
(7). Its presence in the cytosol may be due to contamination during preparation of the antigens, e.g., by its release from the cell
wall during sonication of the bacilli, and it could justify reactivity
to the cytosol. Otherwise, we are rather confident that
cross-contamination represents negligible components of each fraction,
since we found no traces of DnaK, GroEL, or GroES in the culture
filtrates, whereas their presence in the cytoplasm or envelope was
clearly detectable by Western blotting. This finding contrasts with the
data reported for M. tuberculosis, where the heat shock
proteins DnaK, GroEL, and GroES were found in the short-term culture
filtrate (3). Although GroES has been described as a major
T-cell antigen recognized by cells from tuberculosis patients and
infected animals (6, 18), we failed to observe any
reactivity to the fractions of the cytosol expected to contain this
antigen. This might be explained by the fact that only the molecule
isolated from culture filtrates is able to stimulate T cells, as
elegantly shown by Rosenkrands and colleagues (21).
The fractionation techniques utilized in this work are not precise
enough to identify single antigens but are suitable for an initial
screening of the responses against the whole proteome. They are
adequate for the kind of kinetic study presented here, which would be
extremely laborious with other methods, such as those relying on
two-dimensional separation procedures. They also have the advantage of
using native antigens, which may differ from the recombinant products.
The data generated here may, on the other hand, guide us to select
groups of antigens separated through more potent techniques. Our data
also raise interesting speculations regarding the field of vaccine
development by suggesting that antigens from different compartments may
be adequate candidates for the generation of protection. Also, it will
be important to understand whether an improvement on the protective
efficacy of subunit vaccines based on culture filtrate protein can be
obtained by adding proteins from other sources of the mycobacterial
cell. The fact that the responses to the antigens showed distinct
kinetics raises the possibility that antigens from different
compartments may be involved in protection at distinct stages of the
disease. In this context it should be mentioned that vaccination with
HSP60-expressing DNA vaccines had a major impact on experimental
tuberculosis when performed during infection as a therapeutical
vaccine, whereas a similar construct expressing a secreted antigen had
no effect (14); on the other hand, both antigens prevented
infection when given prior to bacillary challenge (3, 23).
It would be interesting to follow up the present observations and
reanalyze the antigenic repertoire in experimental tuberculosis.
Finally, it should be stressed that the reactivities against M. avium proteins observed here were determined by the proteins
expressed during culture in a particular medium. Other proteins
may be expressed in other media and, more importantly, other proteins
may be expressed in vivo and not in vitro. It is therefore still
necessary to broaden this type of analysis to fully understand the
nature of the immunogenic proteome of M. avium in the
context of infection.
 |
ACKNOWLEDGMENTS |
We are indebted to P. Andersen for his support in the setting up of
the analytical methods used, for the gift of reagents, and for fruitful discussions.
The work was supported by contracts ERBIC18CT970254 from the INCO/DC
Programme (European Commission) and BIA247/94 from the PRAXIS Programme
(Lisbon). T.F.P. and J.F.C. received fellowships from PRAXIS.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Laboratory of
Microbiology and Immunology of Infection, Institute for Molecular and Cell Biology, University of Porto, Rua do Campo Alegre 823, 4150-180 Porto, Portugal. Phone: 351.226074952. Fax: 351.226099157. E-mail: rappelb{at}ibmc.up.pt.
Editor:
S. H. E. Kaufmann
 |
REFERENCES |
| 1.
|
Abou-Zeid, C.,
M.-P. Gares,
J. Inwald,
R. Janssen,
Y. Zhang,
D. B. Young,
C. Hetzel,
J. R. Lamb,
S. L. Baldwin,
I. M. Orme,
V. Yeremeev,
B. V. Nikonenko, and A. S. Apt.
1997.
Induction of a type 1 immune response to a recombinant antigen from Mycobacterium tuberculosis expressed in Mycobacterium vaccae.
Infect. Immun.
65:1856-1862[Abstract].
|
| 2.
|
Andersen, P.
1994.
Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins.
Infect. Immun.
62:2536-2544[Abstract/Free Full Text].
|
| 3.
|
Andersen, P.
1997.
Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis.
Scand. J. Immunol.
45:115-131[CrossRef][Medline].
|
| 4.
|
Andersen, P., and I. Heron.
1993.
Simultaneous electroelution of whole SDS-polyacrylamide gels for the direct analysis of complex protein mixtures.
J. Immunol. Methods.
161:29-39[CrossRef][Medline].
|
| 5.
|
Baldwin, S. L.,
C. D'Souza,
A. D. Roberts,
B. P. Kelly,
A. A. Frank,
M. A. Lui,
J. B. Ulmer,
K. Huygen,
D. M. McMurray, and I. M. Orme.
1998.
Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis.
Infect. Immun.
66:2951-2959[Abstract/Free Full Text].
|
| 6.
|
Barnes, P. F.,
V. Mehra,
B. Rivoire,
S.-J. Fong,
P. J. Brennan,
M. S. Voegtline,
P. Minden,
R. A. Houghten,
B. R. Bloom, and R. L. Modlin.
1992.
Immunoreactivity of a 10-kDa antigen of Mycobacterium tuberculosis.
J. Immunol.
148:1835-1840[Abstract].
|
| 7.
|
Belisle, J. T.,
V. D. Vissa,
T. Sievert,
K. Takayama,
P. J. Brennan, and G. S. Besra.
1997.
Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis.
Science
276:1420-1422[Abstract/Free Full Text].
|
| 8.
|
Collins, F. M.,
J. R. Lamb, and D. B. Young.
1988.
Biological activity of protein antigens isolated from Mycobacterium tuberculosis culture filtrate.
Infect. Immun.
56:1260-1266[Abstract/Free Full Text].
|
| 9.
|
Fine, P. E. M.
1988.
BCG vaccination against tuberculosis and leprosy.
Br. Med. Bull.
44:691-703[Abstract/Free Full Text].
|
| 10.
|
Hirschfield, G. R.,
M. McNeil, and P. J. Brennan.
1990.
Peptidoglycan-associated polypeptides of Mycobacterium tuberculosis.
J. Bacteriol.
172:1005-1013[Abstract/Free Full Text].
|
| 11.
|
Huygen, K.,
K. Palfliet,
F. Jurion,
J. Hilgers,
R. ten Berg,
J.-P. Van Vooren, and J. De Bruyn.
1988.
H-2-linked control of in vitro gamma interferon production in response to a 32-kilodalton antigen (P32) of Mycobacterium bovis bacillus Calmette-Guérin.
Infect. Immun.
56:3196-3200[Abstract/Free Full Text].
|
| 12.
|
Leal, I. S.,
B. Smedegård,
P. Andersen, and R. Appelberg.
1999.
Interleukin-6 and interleukin-12 participate in induction of a type 1 protective T-cell response during vaccination with a tuberculosis subunit vaccine.
Infect. Immun.
67:5747-5754[Abstract/Free Full Text].
|
| 13.
|
Lindblad, E. B.,
M. J. Elhay,
R. Silva,
R. Appelberg, and P. Andersen.
1997.
Adjuvant modulation of immune responses to tuberculosis subunit vaccines.
Infect. Immun.
65:623-629[Abstract].
|
| 14.
|
Lowrie, D. B.,
R. E. Tascon,
V. L. D. Bonato,
V. M. F. Lima,
L. H. Faccioli,
E. Stavropoulos,
M. J. Colston,
R. G. Hewinson, and C. L. Silva.
1999.
Therapy of tuberculosis in mice by DNA vaccination.
Nature (London)
400:269-271[CrossRef][Medline].
|
| 15.
|
Lozes, E.,
O. Denis,
A. Drowart,
F. Jurion,
K. Palfliet,
A. Vanonckelen,
J. de Bruyn,
M. de Cock,
J.-P. van Vooren, and K. Huygen.
1997.
Cross-reactive immune responses against Mycobacterium bovis BCG in mice infected with non-tuberculous mycobacteria belonging to the MAIS-group.
Scand. J. Immunol.
46:16-26[CrossRef][Medline].
|
| 16.
|
Morrissey, J.
1981.
Silver stain for proteins in polyacrylamide gels, a modified procedure with enhanced uniform sensitivity.
Anal. Biochem.
117:307-310[CrossRef][Medline].
|
| 17.
|
Orme, I. M.,
P. Andersen, and W. H. Boom.
1993.
T cell response to Mycobacterium tuberculosis.
J. Infect. Dis.
167:1481-1497[Medline].
|
| 18.
|
Orme, I. M.,
E. S. Miller,
A. D. Roberts,
S. K. Furney,
J. P. Griffin,
K. M. Dobos,
D. Chi,
B. Rivoire, and P. J. Brennan.
1992.
T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection. Evidence for different kinetics and recognition of a wide spectrum of protein antigens.
J. Immunol.
148:189-196[Abstract].
|
| 19.
|
Orme, I. M.,
A. D. Roberts,
J. P. Griffin, and J. S. Abrams.
1993.
Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection.
J. Immunol.
151:518-525[Abstract].
|
| 20.
|
Pal, P. G., and M. A. Horwitz.
1992.
Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis.
Infect. Immun.
60:4781-4792[Abstract/Free Full Text].
|
| 21.
|
Rosenkrands, I.,
K. Weldingh,
P. Ravn,
L. Brandt,
P. Højrup,
P. B. Rasmussen,
A. R. Coates,
M. Singh,
P. Mascagni, and P. Andersen.
1999.
Differential T-cell recognition of native and recombinant Mycobacterium tuberculosis GroES.
Infect. Immun.
67:5552-5558[Abstract/Free Full Text].
|
| 22.
|
Silva, R. A.,
T. F. Pais, and R. Appelberg.
1998.
Evaluation of interleukin 12 in immunotherapy and vaccine design in experimental Mycobacterium avium infections.
J. Immunol.
161:5578-5585[Abstract/Free Full Text].
|
| 23.
|
Tascon, R. E.,
M. J. Colston,
S. Ragno,
E. Stavropoulos,
D. Gregory, and D. B. Lowrie.
1996.
Vaccination against tuberculosis by DNA injection.
Nat. Med.
2:888-892[CrossRef][Medline].
|
| 24.
|
Wiker, H. G., and M. Harboe.
1992.
The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis.
Microbiol. Rev.
56:648-661[Abstract/Free Full Text].
|
| 25.
|
Wiker, H. G.,
M. Harboe, and S. Nagai.
1991.
A localization index for distinction between extracellular and intracellular antigens of Mycobacterium tuberculosis.
J. Gen. Microbiol.
137:875-884[Medline].
|
Infection and Immunity, August 2000, p. 4805-4810, Vol. 68, No. 8
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Florido, M., Appelberg, R.
(2007). Characterization of the Deregulated Immune Activation Occurring at Late Stages of Mycobacterial Infection in TNF-Deficient Mice. J. Immunol.
179: 7702-7708
[Abstract]
[Full Text]
-
Florido, M., Pearl, J. E., Solache, A., Borges, M., Haynes, L., Cooper, A. M., Appelberg, R.
(2005). Gamma Interferon-Induced T-Cell Loss in Virulent Mycobacterium avium Infection. Infect. Immun.
73: 3577-3586
[Abstract]
[Full Text]
-
Florido, M., Borges, M., Yagita, H., Appelberg, R.
(2004). Contribution of CD30/CD153 but not of CD27/CD70, CD134/OX40L, or CD137/4-1BBL to the optimal induction of protective immunity to Mycobacterium avium. J. Leukoc. Biol.
76: 1039-1046
[Abstract]
[Full Text]
-
Silva, R. A., Pais, T. F., Appelberg, R.
(2001). Blocking the Receptor for IL-10 Improves Antimycobacterial Chemotherapy and Vaccination. J. Immunol.
167: 1535-1541
[Abstract]
[Full Text]